References
- Anderson, J.M., Shive, M.S., 1997. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev 28, 5-24. https://doi.org/10.1016/S0169-409X(97)00048-3
- Bilati, U., Allemann, E., Doelker, E., 2005. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur. J. Pharm. Biopharm 59, 375-388. https://doi.org/10.1016/j.ejpb.2004.10.006
- Chen, F., O'Dorisio, M.S., Hermann, G., Hayes, J., Malarkey, W.B., O'Dorisio, T.M., 1993. Mechanisms of action of long-acting analogs of somatostatin, Regul. Pept 44, 285-295. https://doi.org/10.1016/0167-0115(93)90138-X
- Gombotz, W.R., Pettit, D.K., 1995. Biodegradable polymers for protein and peptide drug delivery. Bioconjug. Chem 6, 332-351. https://doi.org/10.1021/bc00034a002
- Houchin, M.L., Heppert, K., Topp, E.M., 2006. Deamidation, acylation and proteolysis of a model peptide in PLGA films. J. Control. Release 112, 111-119. https://doi.org/10.1016/j.jconrel.2006.01.018
- Lucke, A., Kiermaier, J., Gopferich, A., 2002. Peptide acylation by poly(alpha-hydroxy esters). Pharm. Res 19, 175-181. https://doi.org/10.1023/A:1014272816454
- Murty, S.B., Thanoo, B.C., Wei, Q., DeLuca, P.P., 2005a. Impurity formation studies with peptide-loaded polymeric microspheres: Part I. In vivo evaluation. Int. J. Pharm 297, 50-61. https://doi.org/10.1016/j.ijpharm.2005.02.035
- Murty, S.B., Na, D.H., Thanoo, B.C., DeLuca, P.P., 2005b. Impurity formation studies with peptide-loaded polymeric microspheres: Part II. In vitro evaluation. Int. J. Pharm 297, 62-72. https://doi.org/10.1016/j.ijpharm.2005.02.034
- Na, D.H., Youn, Y.S., Lee, S.D., Son, M.W., Kim, W.B., DeLuca, P.P., Lee, K.C., 2003. Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry. J. Control. Release 92, 291-299. https://doi.org/10.1016/S0168-3659(03)00366-3
- Na, D.H., DeLuca, P.P., 2005. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide). Pharm. Res 22, 736-742. https://doi.org/10.1007/s11095-005-2589-4
- Na, D.H., Lee, J.E., Jang, S.W., Lee, K.C., 2007. Formation of acylated growth hormone-releasing peptide-6 by poly(lactide-coglycolide) and its biological activity. AAPS PharmSciTech 8, article 43.
- Ryu, K.W., Na, D.H., 2009. Stability of octreotide acetate in aqueous solutions and PLGA films. J. Kor. Pharm. Sci 39, 353-357. https://doi.org/10.4333/KPS.2009.39.5.353
- Sinha, V.R., Trehan, A., 2005. Biodegradable microspheres for parenteral delivery. Crit. Rev. Ther. Drug Carrier Syst 22, 535-602. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v22.i6.20
- Van de Weert, M., Hennink, W.E., Jiskoot, W., 2000. Protein instability in poly(lactic-co-glycolic acid) microparticles, Pharm. Res 17, 1159-1167. https://doi.org/10.1023/A:1026498209874
- Wischke, C., Schwendeman, S.P., 2008. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int. J. Pharm 364, 298-327. https://doi.org/10.1016/j.ijpharm.2008.04.042
Cited by
- Reversible Blocking of Amino Groups of Octreotide for the Inhibition of Formation of Acylated Peptide Impurities in Poly(Lactide-co-Glycolide) Delivery Systems vol.12, pp.4, 2011, https://doi.org/10.1208/s12249-011-9694-y